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Abstract
The majority of Mycobacterium tuberculosis (Mtb) infections remain asymptomatic with only up to 10% progressing to
clinical tuberculosis. However, the constituents of the effective ‘‘protective immunity’’ against tuberculosis responsible for
containing most infections remain unknown. Evaluating gene transcriptional profiles in tuberculosis clinical cohorts is one
approach to understanding the spectrum of tuberculosis progression. It is clear that apoptosis plays a role in the control of
tuberculosis but the utility of apoptosis-related genes as surrogate markers of protection against tuberculosis has not been
well investigated. To characterize potential surrogate markers that could discriminate different phases of the clinical
tuberculosis spectrum, we investigated gene expression of several TNF-alpha dependent apoptotic genes (TNFR1, TNFR2,
FLICE, FLIPs) by real-time RT-PCR of peripheral blood cells from cohorts of individuals with active tuberculosis or potential
exposure to tuberculosis. Newly diagnosed tuberculosis patients (n = 23), their close household contacts (n = 80), and
community controls (n = 46) were tested at intervals over a period of up to two years. Latent infection or previous Mtb
contact was assessed by ELISPOT and TST and complete blood counts were performed during the follow up. Results
showed significant upregulation of FLIPs expression by infected individuals regardless of clinical status at entry to the study.
A higher percentage of lymphocytes was found in the infected household contacts that remained healthy. In contrast, in
individuals with active TB, a significant upregulation of TNFR2 expression, a significantly higher percentage of monocytes
and a significantly decreased lymphocyte count were seen, compared to subjects that remained healthy. Moreover, the
household contacts who subsequently developed signs of TB also had a significantly high number of monocytes. These
data suggest tuberculosis may be associated with decreased T-cell survival (perhaps due to apoptosis) while inhibition of
apoptosis in monocytes could lead to a relative increase in these cells: a situation predicted to favour Mtb.
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Introduction
It has been estimated that a third of the world population is
infected with bacteria from the Mycobacterium tuberculosis complex
(MTC). These bacteria are the causal agents of tuberculosis (TB), a
major cause of morbidity and mortality worldwide. Most infected
individuals remain asymptomatic, but up to 10% can go on to
develop active TB disease, becoming contagious during a period of
months to decades after initial infection [1]. Current diagnostic
tests for tuberculosis can detect previous exposure to members of
the MTC. However, these tests cannot distinguish between
previous infection and active disease, and this greatly hampers
TB control programs. The development of effective diagnostic
tests for TB and the identification of biomarkers of disease status
are therefore urgently required. Furthermore, as the protective
immune response to TB in humans has not been clearly defined, it
is difficult to identify the infected individuals likely to develop
active disease and requiring treatment. The vast numbers of
individuals infected annually makes it impossible to consider
treating all latent infections. The identification of risk factors for
the development of active TB, and the monitoring of treatment
success or of the protection provided by vaccines would all be vital
steps towards containment of the TB epidemic [2], [3].
A strong cell-mediated immune (CMI) inflammatory response,
involving tumor necrosis factor-alpha (TNF-a) and interferon-
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gamma (IFN-c), is rapidly induced by infection with MTC and is
required to protect the infected host against TB [4]. However,
MTC can survive this inflammatory process and multiply within
macrophages, by interfering with phagosome development,
leading, in most cases, to a latent infection that may subsequently
be reactivated, causing TB disease [3], [5]. Apoptosis seems to
play an important role in the CMI response and TB control [6],
[7]. The apoptosis of infected cells may limit bacterial growth by
causing lysis of the bacteria within the apoptotic host cell, leading
to the presentation of MTC antigens to T cells [8,9]. It has also
been suggested that the pathogen may use anti-apoptotic
mechanisms to ensure its survival and growth within infected cells
and to inhibit the development of T-cell immunity [10]. TNF-a
appears to play a crucial role in reinforcing the host response to
the pathogen [11] and TNF-a-dependent apoptosis seems to be a
key element of immunity to TB. Various studies have suggested
that molecules from the TNF-a family are involved in the
apoptosis of macrophages or other cells infected with intracellular
bacteria, including MTC [12]. For example, some virulent
laboratory strains can induce the shedding of the TNF-a receptor
(sTNFR2), which continues to bind its ligand, acting as a soluble
antagonist of TNF-a preventing the lysis of infected host cells [13].
TNF-a acts through its membrane receptors, TNFR1 and
TNFR2, which aggregate with other membrane and cytosolic
proteins to form the ‘‘death-receptor complex’’ [14]. Signaling by
these receptors initiates a cascade of reactions activating the
proteins of the ‘‘death-signaling complex’’ (DISC), thereby
initiating apoptosis [15] and limiting the replication of the
intracellular bacteria [16]. Caspase-8 or FLICE is an essential
pro-apoptotic component of the DISC, as is its antagonist, the
FLICE-inhibitory protein or FLIP, which has a similar structure to
FLICE but no catalytic activity and inhibits apoptosis. Recent
observations have suggested that the DISC and certain ‘‘death-
receptor domain’’ molecules are also involved in the activation and
proliferation of T cells [17,18]. The outcome of an MTC infection
therefore probably depends on the balance between the various
immune processes.
MTC may stimulate apoptotic death in a subset of T cells, by
triggering the release of large amounts of TNF-a, while preserving
their host cell by inhibiting the response to TNF-a and increasing
the production of anti-apoptotic factors [19,20,21,22,23]. In this
study, we tested this hypothesis in cohorts of TB patients, their
recent household contacts and community controls from Mada-
gascar, by using reverse transcriptase quantitative PCR (RT-
qPCR) to assess the expression of the TNFR1 and TNFR2, FLICE
and FLIPs genes and evaluating cell counts.
Materials and Methods
Ethics statement
The participants were enrolled after they had received
counseling and an explanation of the study. Only participants
who gave written informed consent were included in this study.
For minors and children, written informed consent was obtained
from the next of kin.
The National Ethics Committee of the Ministry of Health of
Madagascar approved the study (Authorization No. 038-SANPF/
CAB, February 20th 2004).
Study site and subjects
Adult TB patients with a recent diagnosis based on a smear
positive for acid-fast bacilli (AFB) (index cases [IC], over 15 years
of age) were recruited at the principal anti-tuberculosis center in
Antananarivo. Positivity was defined as two sputum samples
classified positive by microscopy, with confirmation by culture on
Lowenstein-Jensen medium. The household contacts (HC) of the
included IC were visited at home by the study physicians and
asked to participate in the study. They were included if they were
at least one year old and had been living in the same house as the
IC for at least six months. The subjects (or their legal guardians,
for children) were informed about the study, their consent was
then sought and they were interviewed and examined. Only
subjects who agreed to undergo an HIV test, after counseling
(where appropriate), and who had given informed consent were
included in the study.
For every TB index case, two community controls (CC) were
selected. These controls were healthy volunteers from the
dispensary of the Pasteur Institute of Madagascar, matched for
age and sex with two HC.
In total, we recruited 163 HIV-seronegative subjects: 25 IC, 88
HC and 50 CC. HC and CC had no TB symptoms and a chest X-
ray on inclusion revealed no evidence of TB. Contacts were
regularly monitored, at three month intervals, for up to two years
after inclusion, to check for the development of TB symptoms.
For all subjects, epidemiological, clinical and bacteriological
data were recorded prospectively on individual record forms.
Blood samples were collected on inclusion in the study and at the
end of eight months of anti-TB treatment for the IC. For HC and
CC, blood samples were collected on inclusion and three months
after inclusion.
Blood tests and white blood cell count differences
Venous blood samples were collected into EDTA-coated
Vacutainer tubes and stored at room temperature until analysis.
White blood cell (WBC) count was determined with an automated
ABX Pentra 120 Retic hematological analyzer (ABX, Montpellier,
France). A biologist independently validated the assays.
Table 1. Sequences of the primers and probes used to
quantify gene expression by real-time PCR.
Gene Nucleotide sequence
Product
size (bp) R2
HuPO L: GCTTCCTGGAGGGTGTCC 105 0.99
P: TGCCAGTGTCTGTCTGCAGATTGG
R: GGACTCGTTTGTACCCGTTG
TNFR1 L: CGGTGGAAGTCCAAGCTCTA 114 0.98
R: GGGACTGAAGCTTGGGTTT
P: CTGAAAAAGAGGGGGAGCTTGAAGGA
TNFR2 L: ACCGTGTGTGACTCCTGTGA 101 0.99
R: TCCACCTGGTCAGAGCTACA
P: ACTGGGTTCCCGAGTGCTTGAGCT
FLIP L: GTTCAAGGAGCAGGGACAAG 114 0.99
R: ATCAGGACAATGGGCATAGG
P: TGGATTGCTGCTTGGAGAACATTCC
FLICE L: AAGTGCCCAAACTTCACAGC 102 0.98
R: GGGGCTTGATCTCAAAATGA
P: ACTTGGATGCAGGGGCTTTGACCAC
L: Left primer (59--------39).
R: Right primer (59--------39).
P: Probe (59 FAM--------TAMRA 39).
doi:10.1371/journal.pone.0061154.t001
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Tuberculin skin test (TST) and ELISPOT assays were
performed to check for previous exposure of the various subjects
to MTC as described in a previous study [24]. Briefly, at the time
of inclusion, physicians performed a standard Mantoux test and
the results were read after 72 h. A cutaneous induration greater of
5 mm or more in diameter was considered to indicate a positive
TST response and an induration of more than 14 mm in diameter
was considered to indicate high reactivity. Peripheral blood
mononuclear cells (PBMCs) were isolated from venous blood
and stimulated with M. tuberculosis (Mtb) antigens for the
quantification of IFN-c production by ELISPOT. Briefly, PBMCs
were isolated from heparinized whole blood by centrifugation on a
Ficoll gradient. For each sample, we added 26105 PBMCs, in
duplicate, to biotinylated anti-IFN-c-coated 96-well plates (MAIP
S 45; Millipore). PBMCs were stimulated with either PPD (Mtb
purified protein derivative), or the 6 kDa early secretory antigenic
target (ESAT-6) from Mtb and were incubated overnight, at 37uC,
under an atmosphere containing 5% CO2, before staining by
incubation with streptavidin peroxidase conjugate. The mean
number of spot-forming cells (SFCs) of the negative control was
subtracted from the number of SFCs per 26105 cells. The cutoff
point for positivity was defined as the mean response of
unstimulated wells for the whole cohort plus 1.64 standard
deviations.
RNA extraction and reverse transcription
Blood samples (2.5 ml) were collected in PAXgene blood tubes
(PreAnalytix, Qiagen). Total RNA was extracted with the
PAXgene RNA kit (PreAnalytix, Qiagen), according to the
manufacturer’s instructions, and RNA quality was assessed by
checking for the presence of two rRNA bands on agarose
electrophoresis gels and by quantification with a NanoDrop
1000 (Thermo Scientific). All samples were treated with RNase-
Free DNAse (Qiagen) according to the manufacturer instructions
before reverse transcription. We then generated cDNA from
300 ng of total RNA per sample, with the Omniscript RT kit
(Qiagen) and oligo (dT) primers, according to the manufacturer’s
instructions. The cDNA aliquots were stored at 280uC until use.
Quantification of the expression of apoptosis-associated
genes by RT-qPCR
We assessed the expression of the TNFR1, TNFR2, FLICE and
FLIPs genes, by carrying out RT-qPCR. The primers and dual-
labeled probes (59-FAM—TAMRA-39) specific for each apoptotic
marker studied were designed to span introns, to prevent
amplification from genomic DNA (see list in Table 1). The
QuantiTect Probe Master Mix kit (Qiagen) was used for real-time
PCR, according to the manufacturer’s instructions. Each reaction
was performed in a volume of 25 ml, corresponding to 5 ml of
cDNA and 20 ml of master mix. The gene encoding the human
ribosomal protein HUPO was used as reference gene, to control
for variation in the level of nucleic acid in the sample [25]. A
Rotor-Gene (Corbett Research, Sydney, Australia) was used for
real-time PCR. The PCR conditions were as follows: incubation
for 15 minutes at 95uC, followed by 45 cycles of denaturation at
95uC for 10 seconds, annealing for 20 seconds and then extension
at 72uC for 30 seconds. The fluorescence emitted was acquired at
the end of every extension step. The reaction efficiency
(range= 90–100%) was determined by serial dilution of a known
quantity of plasmid clones for each gene, as previously described
[26]. All reactions were performed in duplicate and the duplicate
results had a standard deviation ,0.4 of the mean. Controls,
including tubes with no template for reverse transcription
reactions, were included in each run. The numbers of copies of
the mRNA for the various apoptosis-associated genes were then
normalized to 105 copies of the mRNA for the housekeeping gene
encoding HUPO.
Statistical analysis
The data obtained were analyzed by PCR with Rotor-Gene 6.0
software (build 23) from Corbett Research. Data were analyzed
with Epi Info version 6.04dfr (CDC, USA and WHO, Switzer-
land) and groups were compared in nonparametric Kruskal-Wallis
tests, with ANOVA used as a parametric tests, where appropriate
(according to the variance comparison in Bartlett’s chi-squared of
variances homogeneity test). A p value,0.05 was considered
statistically significant.
Results
Analysis of TB dynamics in a TB endemic country
population
A full set of results was available for 149 (23 IC, 80 HC, 46 CC)
of the 163 subjects who agreed to participate in the study. During
follow-up, 10 HC from eight different families developed TB-like
symptoms (symptomatic HC or sHC), although their AFB smears
remained negative. These subjects were assumed to be possible
cases of early-stage TB. The other 70 HC remained healthy
(healthy HC or hHC) during the follow-up period.
The proportion of BCG-vaccinated subjects (ascertained on the
basis of vaccination scars, vaccination declarations and a review of
medical records) ranged from 80% to 91.3%, and no significant
differences in this proportion were found between the four clinical
groups (Table 2). Neonates are routinely vaccinated with BCG in
Madagascar. The TST was negative for one third of the BCG-
Table 2. Characteristics of the cohorts recruited for the study.
Cohort IC hHC sHC CC
No. individuals 23 70 10 46
Mean age, years
[range]
32.48
[17–70]
21.94
[4–68]
18.1
[5–47]
22.35
[5–70]
Sex M 10 33 5 21
F 13 37 5 25
TST at inclusion
Negative 2 17 2 24
5–14 mm 8 26 0 8
$15 mm 7 27 8 14
ND 6 10 0 0
BCG vaccination
Yes 20 (87%) 62 (88.5%) 8 (80%) 42 (91.3%)
No 2 3 1 1
ND 1 15 1 3
PPD ELISPOT
Negative (%) 1 (4.3%) 11 (15.7%) 0 13 (28.3%)
Positive (%) 14 (60.9%) 37 (52.9%) 5 (50%) 24 (52.2%)
ND 8 22 5 9
ESAT-6 ELISPOT
Negative (%) 5 (21.7%) 23 (32.9%) 3 (30%) 18 (39.1%)
Positive (%) 10 (43.5%) 25 (35.7%) 2 (20%) 19 (41.3%)
ND 8 22 5 9
doi:10.1371/journal.pone.0061154.t002
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vaccinated subjects, and an induration .14 mm in diameter was
observed in some individuals that had not been vaccinated (data
not shown). No significant correlation was observed between the
TST response and BCG vaccination status. No significant
difference in TST response or PPD ELISPOT IFN-c production
was observed between the clinical groups (Table 2).
Differences in TNFR2 and FLIPs expression in peripheral
blood were associated with clinical status for TB
Total mRNA was extracted from blood samples collected on
inclusion and at the various times during follow-up, as noted in the
Materials and Methods. TNFR1, TNFR2, FLIPs and FLICE
mRNAs were quantified with normalization with respect to 105
copies of HUPO mRNA. Levels of TNFR2 mRNA were
significantly higher in the IC than in the CC on inclusion
(p=0.03), and those of the HC were intermediate between these
two groups (Figure 1B). The copy numbers of mRNA molecules
for the other genes tested (TNFR1, FLIPs and FLICE) did not differ
significantly between the clinical groups (p=NS, figure 1).
High levels of TNFR2 expression were associated with TB
disease. The levels of the four markers in IC at the end of anti-TB
treatment were similar to those on inclusion in the study (p.0.05,
data not shown).
By contrast, FLIPS was significantly more strongly expressed
after three months of follow-up than on inclusion in the HC
(p=,0.01), whereas the level of expression of this marker
remained unchanged in the matched community controls
(figure 2C).
FLIPs expression segregated according to TST and IFN-c
ELISPOT results
All groups, except the IC group who all have confirmed
infection, had the potential to display heterogeneity in terms of
Mtb exposure: not all contacts are necessarily infected (although we
would expect most to be infected) and the CC group would be
expected to include some with latent tuberculosis infection (LTBI).
We therefore compared the expression of the target genes in TST-
positive and TST-negative individuals. FLIPs expression was
significantly stronger in the TST-positive (induration .5 mm)
Figure 1. Expression of apoptotic genes in the blood between groups differing in clinical status for TB. (A) TNFR1 expression, (B) TNFR2
expression, (C) FLIPs expression, (D) FLICE expression. The data shown are the median and ranges of mRNA levels normalized and expressed as the
number of copies per 105 copies of mRNA for the housekeeping gene, HuPO. Mann-Whitney U tests were used for the pairwise comparison of groups.
Significant differences in gene expression between clinical groups are indicated by a horizontal bar with the corresponding p value.
doi:10.1371/journal.pone.0061154.g001
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subjects than in the TST-negative subjects, in all clinical groups
(figure 3C). A comparison of apoptotic gene expression segregated
by PPD ELISPOT results showed that all the genes studied (FLIPs,
FLICE, TNFR1 and TNFR2) were more strongly expressed in PPD
ELISPOT-positive individuals than in PPD ELISPOT-negative
individuals (Figure 3). However, only FLIPs expression was
significantly stronger in the ESAT-6 ELISPOT-positive individ-
uals than in the ESAT-6 ELISPOT-negative individuals (p,0.05,
figure 3), with no difference observed for the other genes studied.
Furthermore, an analysis of each clinical group segregated by TST
response showed that, within the hHC group, FLIPs expression
was significantly stronger in individuals with a positive TST than
in those with a negative TST (p#0.01, figure 4) but no difference
was seen for the other genes or clinical groups. All four genes were
significantly more strongly expressed in the PPD ELISPOT-
positive hHC and CC than in the non-responders (p,0.05,
Figure 5). Nothing can be said about the IC group in this regard,
since all but one were PPD, ELISPOT positive. Finally
segregation of each clinical group by ESAT-6 responsiveness gave
a result resembling the TST analysis. Within the hHC group,
FLIPs expression was significantly stronger in those with a positive
result for ESAT-6 ELISPOT than in hHC with a negative ESAT-
6 ELISPOT result (p=0.02, Figure 6).
This association of elevated expression of FLIPs with TST and
ELISPOT positivity indicates it may be related to infection.
Assessment of WBC composition in the different clinical
groups
We investigated the correlation between the expression of the
apoptotic genes studied and differences in the composition of the
Figure 2. Comparison of peripheral blood gene expression in the contacts and controls after 3 months of follow-up. Expression on
inclusion in the study (M0) and after 3 months of follow-up (M3) for (A) TNFR1, (B) TNFR2, (C) FLIPs and (D) FLICE. The data shown are the median and
ranges for mRNA levels normalized and expressed as the number of copies per 105 copies of the mRNA for the housekeeping gene, HuPO. Mann-
Whitney U tests were used for the pairwise comparison of groups. Significant differences between the testing periods are shown. HC: household
contact, CC: community control.
doi:10.1371/journal.pone.0061154.g002
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WBC population, by analyzing the overall distribution of the
WBC population (Table 3). Total WBC count was significantly
higher in the hHC group than in the CC group (p=0.02).
Similarly, the TB patients (IC and sHC) had a significantly higher
percentage of monocytes and neutrophils (p,0.05) but a lower
percentage of lymphocytes, compared to the healthy subjects
(hHC and CC) (Figure 7). Interestingly, this finding is compatible
with recent data from 2 large cohort studies in India, using
Multiplex ligation-dependent probe amplification, suggesting that
it may be a generally applicable finding (Author’s unpublished
data). After treatment of TB patients, the neutrophil and the
monocyte percentages decreased, while the lymphocyte percent-
age increased, erasing the difference between clinical groups (data
not shown).
No significant correlation was observed between the expression
levels of the four apoptotic genes studied and differences in WBC
population distribution in the various clinical groups (IC with
active TB, HC exposed to TB and CC; table 3).
Apoptotic gene expression and WBC rates distinguish
between healthy subjects, individuals with Mtb infection
and individuals with active TB
As TB is endemic in Madagascar and the coverage rate is high
for BCG vaccination, a weak TST response may not be specific for
a Mtb infection. We thus defined infection as a strong TST
response and assumed that healthy individuals with an induration
in the TST,14 mm were potentially pre-sensitized to mycobac-
teria but not necessarily infected withMtb, and further that healthy
individuals, with a TST result,5 mm were most likely not
infected. Those with a TST.14 were assumed to be infected with
Mtb, even if asymptomatic
In infected healthy subjects, the number of copies of FLIPs
mRNA in the hHC (177.786219.9, n= 27) was greater than that
in the CC group ((75.9688.84, n= 15; p,0.01), while the levels of
expression of the other genes studied did not differ between the
two groups. The individuals with signs of TB disease (IC and sHC)
also had higher levels of TNFR2 mRNA in the peripheral blood
Figure 3. Peripheral blood gene expression as a function of TST, PPD-IFN-c-ELISPOT and ESAT-6 ELISPOT responses. (A) TNFR1, (B)
TNFR2, (C) FLIPs and (D) FLICE. The data shown are the median and ranges of mRNA levels normalized and expressed as the number of copies per 105
copies of mRNA for the housekeeping gene, HuPO. The threshold for TST positivity was fixed at .5 mm. Neg, TST induration ,5 mm, Pos, TST
induration $5 mm in diameter. ELISPOT positivity was defined as described by Rakotosamimanana et al., 2010. Individuals with a negative response
are shown in white, those with a positive response in grey. Significant differences in gene expression between clinical groups are indicated.
doi:10.1371/journal.pone.0061154.g003
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than did healthy infected subjects with an induration in the
TST.14 mm (p=0.04; Table 4).
The TB symptomatic individuals (IC and sHC) had significantly
higher monocyte counts than the infected but healthy (i-hHC) or
non infected individuals (NI-CC) ((p,0.05, figure 8A). The sHC
had a percentage of monocytes, significantly higher than those of
individuals with a different clinical status (figure 8A). The IC had a
significantly higher proportion of neutrophils than the healthy
individuals (i-hHC and NI-CC; figure 8B). Moreover, the healthy
infected individuals (i-hHC) had significantly higher lymphocyte
proportions than both the IC and the NI-CC (figure 8C).
We tried to identify the characteristics distinguishing between
those individuals who were able to control their infection and
those who became ill (protected and non protected) by analysing
the data on the factors which were different between the groups,
namely FLIPs and TNFR2 expression, and lymphocyte and
monocyte counts. Combination of these four factors (Figure 9)
gives a signature that could distinguish the IC group, infected hHC
(i-hHC with TST.14 mm) and non infected CC (NI-CC with
TST,5 mm). According to these parameters, high levels of FLIPs
expression were associated with Mtb infection, but those who are
able to maintain a higher ratio of lymphocytes and low monocyte
levels are able to control this infection.
Discussion
The progression of Mtb infection to active TB disease may take
several years to decades, and infections may remain asymptomatic.
Individuals with LTBI constitute a major reservoir of potential
new active TB cases that could maintain the pandemic transmis-
sion of TB. This study was driven by the need for the
characterization of surrogate markers of a protective immune
response to Mtb infection or of progression to active TB disease.
Current diagnostic tests for TB cannot distinguish between
active disease and latent Mtb infection. Some diagnostic tests are
based on the cell-mediated immunity of the host against Mtb
Figure 4. Blood expression of apoptotic genes as a function of TST response in the clinical groups. (A) TNFR1, (B) TNFR2, (C) FLIPs, (D)
FLICE. TST positivity was defined as an induration.5 mm in diameter. Neg, TST induration,5 mm, Pos, TST induration$5 mm in diameter. The data
shown are the median and ranges of mRNA levels normalized and expressed as a number of copies per 105 copies of mRNA for the housekeeping
gene, HuPO. Significant differences in gene expression between clinical groups are shown.
doi:10.1371/journal.pone.0061154.g004
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where a Th1 cytokine profile response has an important role, but
this response is apparently unable to distinguish active disease
from latent Mtb infection. TNF-a is an important part of this
response, as indicated by the reactivation of disease by anti-TNF-a
therapy [27]. We therefore looked at TNF-a-stimulated apoptotic
genes since apoptosis of infected macrophages also plays an
important role in controlling Mtb infection and regulating cell-
mediated immunity to the pathogen [13,15,28,29]. The expression
of four genes associated with TNF-a-dependent apoptosis and
downstream apoptotic effectors was quantified in the peripheral
blood of patients with active TB, their household contacts and
matched community controls.
As summarized in figure 9, the different clinical groups could be
characterized on the basis of a combination of expression levels for
FLIPs and TNFR2 and the distributions of lymphocytes and
monocytes in peripheral blood. Higher levels of expression of
FLIPs in the peripheral blood seemed to be associated with Mtb
infection, as FLIPs mRNA in the i-hHC and IC were significantly
higher than those in the other groups. This higher level of FLIPs
mRNA was also found in TST-positive and PPD or ESAT-6
ELISPOT-positive individuals. FLIPs gene expression was also
significantly upregulated in the HC after three months of follow-
up, as shown by comparisons with mRNA levels on inclusion in
the study, while no such change was observed over the same
period for the CC group, consistent with our hypothesis that
elevated expression of FLIPs in this cohort reflects infection with
Mtb.
However, not all Mtb infections lead to TB disease. The hHC
identified as infected by TST and ELISPOT positivity who
nonetheless remained healthy throughout the follow-up period
had elevated expression of FLIPs but also an elevated percentage
of peripheral blood of lymphocytes. This may reflect an active T
cell response against Mtb. In the TB patients, elevated expression
of FLIPsmRNA was also observed, but in this case, associated with
Figure 5. Peripheral blood gene expression as a function of PPD-IFN-c-ELISPOT response in the clinical groups. (A) TNFR1, (B) TNFR2,
(C) FLIPs, (D) FLICE. ELISPOT positivity was defined as described in the Materials and Methods. The data shown are the median and ranges of mRNA
levels normalized and expressed as the number of copies per 105 copies of mRNA for the housekeeping gene, HuPO. Significant differences in gene
expression between clinical groups are indicated.
doi:10.1371/journal.pone.0061154.g005
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Figure 6. Peripheral blood gene expression as a function of ESAT-6 ELISPOT response in the clinical groups. (A) TNFR1, (B) TNFR2, (C)
FLIPs, (D) FLICE. The data shown are the median and ranges of mRNA levels normalized and expressed as a number of copies per 105 copies of mRNA
for the housekeeping gene, HuPO. Significant differences in gene expression between clinical groups are indicated.
doi:10.1371/journal.pone.0061154.g006
Figure 7. Peripheral blood cell distribution as a function of the presence or absence of TB symptoms. (A) Monocytes, (B) neutrophils
and (C) lymphocytes. The data shown are the mean cell percentage+SD. Significant differences in gene expressions between clinical groups are
indicated. TB, index cases and household contacts presenting TB symptoms.
doi:10.1371/journal.pone.0061154.g007
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a significant upregulation of TNFR2 gene expression and an
increased ratio of monocytes to lymphocytes. The fact that this
ratio reverts to that seen in healthy individuals after successful
treatment of TB is consistent with the idea that the T cell
population may be inhibited in active TB. The contacts who
developed TB-like symptoms in the course of follow-up (sHC)
showed an intermediate pattern, with levels of FLIPs expression
consistent with infection, and an elevated monocyte to lymphocyte
ratio, but without significantly increased TNFR2 expression.
These results confirm and expand earlier work. In studies of TB
patients, their household contacts and community controls from
Ethiopia, Abebe and collaborators also observed a difference in
apoptotic gene expression in the different clinical cohorts. This
study suggested that monocytes from the Ethiopian TB patients
were less sensitive to TNF-a-dependent apoptosis than the other
cell lineages (notably T-cells), due to shedding of the TNFR2
receptor by monocytes [26]. These findings are consistent with the
data reported here, and moreover provide a mechanism to explain
these results.
The inhibition of TNF-a dependent apoptosis of infected
macrophage has been suggested as a mechanism used by Mtb to
preserve its intracellular niche and escape the host immune
response [21] and it has been observed that virulentMtb strains are
able to directly inhibit TNF-a-dependent apoptosis of macro-
phages by activating the release of membrane-bound TNFR2 as
the soluble form by infected host cells [13]. Similarly, observations
from Mtb-induced apoptosis models suggested that FLIPs degra-
dation was associated with TNF-induced apoptosis of Mtb infected
macrophages. [15]. The higher level of FLIPs in Mtb-infected
individuals in this study is concordant with the different in vitro
observations and suggests that Mtb-induced increase of FLIPs may
reflect an attempt by the pathogen to protect macrophages – the
pathogen’s preferred host cell – from TNF-a-dependent apoptosis.
Whether this leads to latent infection or TB disease appears to
correlate with the relative preservation or loss, respectively of
lymphocytes in the peripheral blood of infected individuals, with a
loss of T cell numbers correlating with the development of TB, as
previously suggested [30,31]. While most of these other studies
were performed in vitro or in active TB patients, the current
observations from the Malagasy cohort suggests that this
mechanism is also active in infected household contacts and that
early signs of monocyte/lymphocyte imbalance may identify those
individuals who are failing to contain the infection.
Also supportive of our results, a recent microarray study on
human TB has shown a significant decrease of lymphocytic cells
and an increase of myeloid lineage transcripts in active TB
patients, which was attributed to an expansion of inflammatory
monocytes (CD14+CD16+) [31]. Further longitudinal studies to
characterise monocytic subpopulations in TB contacts are
therefore potentially very interesting.
The mechanism involved in the relative decrease in lympho-
cytes is as yet unclear. Observations from other studies in TB
patients suggested a significant decrease in the number of certain
Mtb-reactive T cells and a decreased production of IFN-c was
linked with activation of some apoptotic pathways [22,23]. A
Gambian study also found that a relative decrease in CD4 T cells
in TB contacts was correlated with risk of subsequent TB, though
the mechanism was not indicated [30]. The hypothesis that
imbalances in regulation of apoptosis may lead to a loss of immune
function and subsequent progress to TB is therefore an attractive
one; however more work is required before we can say anything
definitive about cause and effect. These results do however,
highlight the importance of a better understanding of the role of
apoptosis in the development of TB.
Conclusions
In this study, we evaluated the utility of both gene expression
and cell proportions, as combined markers for characterizing the
protective response against TB in humans.
Changes in the expression of TNF-associated apoptotic genes
seemed to be associated with changes in the distribution of
immune cells in the peripheral blood of various clinical groups
defined on the basis of TB status. An increase in FLIPs expression
seemed to be associated with Mtb infection. In infected individuals
who remained healthy, this FLIPs increase was associated with a
higher ratio of lymphocytes to monocytes, while infected contacts
who later developed TB-like symptoms showed the reverse
pattern: a significant elevation of the ratio of monocytes to
lymphocytes in the peripheral blood. TB index cases were also
characterized by an elevated ratio of monocytes to lymphocytes
and this reversed after successful treatment. Like infected contacts,
TB patients had increased expression of FLIPs, when compared to
healthy individuals but additionally displayed an increased level of
expression of mRNA for TNFR2. Prior studies indicate that
increased expression of the TNFR2 gene by TB patients is
associated with increased levels of serum soluble TNFR2 [26]
Table 3. Hematological characteristics.
Cohort IC hHC sHC CC p value
No. individuals 24 69 8 46
RBC (6102/l) 4.792 5.101 4.875 4.935 0.130952
Hemoglobin
concentration (g/l)
124.125 139.928 130.500 137.717 0.000427
MCV (m3) 79.958 82.971 81.250 85.435 0.002287
MCH (pg) 26.750 27.957 27.375 28.478 0.009976
MCHC (g/l) 318.875 334.348 335.250 330.217 0.031949
Leukocytes (6109/l) 6.250 6.870 6.375 5.826 0.130369
Neutrophiles (%) 56.958 48.768 50.375 48.591 0.028549
Neutrophils (6109/l) 3.583 3.377 2.750 3.000 0.323279
Lymphocytes (%) 29.333 40.464 39.375 37.909 0.000726
Lymphocytes (6109/l) 1.750 2.623 2.375 2.067 0.000157
Monocytes (%) 7.583 6.116 10.375 6.727 0.000079
Monocytes (6109/L) 0.333 0.290 0.625 0.222 0.139802
Platelets (6109/l) 397.958 291.072 371.750 287.000 0.000153
The mean values are given for each clinical group.
MCHC: mean corpuscular hemoglobin concentration; MCV: mean corpuscular
volume; MCH: mean corpuscular hemoglobin (amount).
doi:10.1371/journal.pone.0061154.t003
Table 4. Apoptotic gene expression in individuals with
TST.14 mm.
Markers TB (n=15) ±SD Healthy (n=42) ±SD p-value
TNFR1 276,1 381,3 178 406,5 0,9639
TNFR2 241,4 771 71,19 232,8 0.039
FLIPs 104,4 141,5 124,2 194,6 0,3794
FLICE 67,18 83,32 47,39 86,2 0,491
TB= active TB and symptomatic (IC+sHC). SD = standard deviation. The mean
values are given for each clinical group.
doi:10.1371/journal.pone.0061154.t004
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Figure 8. Peripheral blood cell proportions as a function of clinical status group. (A) Monocytes, (B) neutrophils and (C) lymphocytes. The
data shown are the mean+SD of cell percentage. NI-CC=Non infected community control (CC with TST induration,5 mm), i-hHC= infected
household contact (TST induration $14 mm), sHC=household contact that developed TB symptoms, IC = index TB case. Significant differences in
gene expression between clinical groups are indicated.
doi:10.1371/journal.pone.0061154.g008
Figure 9. FLIPs and TNFR2 expressions in combination with lymphocyte and monocyte proportions to characterize clinical status. NI-
CC =Non-infected community control (CC with TST induration ,5 mm), i-hHC= infected household contact (TST induration $14 mm),
sHC=household contact developing TB symptoms, IC = index TB case. In dark gray: significant increase; in light gray: significant increase in
community control; in black: significant increase in sHCs, hatched: non particular pattern of response identified. Significant differences are indicated
with stars.
doi:10.1371/journal.pone.0061154.g009
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which acts as a TNF-a antagonist, suggesting the same is likely
true in this study.
While these data are the first to suggest that FLIPs might be a
promising marker of Mtb infection, and that the combination of
apoptotic genes and monocyte/lymphocyte markers may allow us
to predict risk of progression from infection to full-blown TB,
further studies are required to ascertain the usefulness of the
observed parameters as surrogate markers of TB clinical status.
Other factors influencing apoptosis and immune responses should
be studied in a more integrative manner, with parallel studies of
the genetics of human populations or Mtb strains, to improve our
understanding of the disease and facilitate the development of new
tools for combating tuberculosis.
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